Wai Yuen Tong Medicine Holdings Ltd

HKSE:00897 (Hong Kong)  
HK$ 0.22 (-1.82%) Jun 7
7.20
P/B:
0.11
Market Cap:
HK$ 243.02M ($ 31.11M)
Enterprise V:
HK$ 1.37B ($ 175.99M)
Volume:
11.87K
Avg Vol (2M):
1.03M
Volume:
11.87K
Avg Vol (2M):
1.03M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Wai Yuen Tong Medicine Holdings Ltd ( ) from 1997 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Wai Yuen Tong Medicine stock (HKSE:00897) PE ratio as of Jun 10 2024 is 7.2. More Details

Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) PE Ratio (TTM) Chart

To

Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) PE Ratio (TTM) Historical Data

Total 1159
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 13
Wai Yuen Tong Medicine PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-10 7.2 2024-04-03 8.3
2024-06-07 7.2 2024-04-02 8.2
2024-06-06 7.3 2024-03-28 8.1
2024-06-05 7.3 2024-03-27 8.3
2024-06-04 7.5 2024-03-26 8.3
2024-06-03 7.5 2024-03-25 8.2
2024-05-31 7.5 2024-03-22 7.5
2024-05-30 7.5 2024-03-21 8.0
2024-05-29 7.5 2024-03-20 7.5
2024-05-28 7.4 2024-03-19 7.5
2024-05-27 7.3 2024-03-18 7.6
2024-05-24 7.3 2024-03-15 7.3
2024-05-23 7.5 2024-03-14 7.9
2024-05-22 7.5 2024-03-13 8.5
2024-05-21 7.6 2024-03-12 8.3
2024-05-20 7.6 2024-03-11 7.5
2024-05-17 7.6 2024-03-08 3.8
2024-05-16 7.6 2024-03-07 3.6
2024-05-14 7.6 2024-03-06 3.7
2024-05-13 7.6 2024-03-05 3.7
2024-05-10 7.7 2024-03-04 3.6
2024-05-09 8.3 2024-03-01 3.6
2024-05-08 7.7 2024-02-29 3.6
2024-05-07 7.6 2024-02-28 3.6
2024-05-06 7.6 2024-02-27 3.6
2024-05-03 7.7 2024-02-26 3.6
2024-05-02 7.7 2024-02-23 3.5
2024-04-30 7.6 2024-02-22 3.5
2024-04-29 7.7 2024-02-21 3.4
2024-04-26 7.7 2024-02-20 3.5
2024-04-25 7.7 2024-02-19 3.5
2024-04-24 7.7 2024-02-16 3.4
2024-04-23 7.5 2024-02-15 3.4
2024-04-22 7.8 2024-02-14 3.4
2024-04-19 8.1 2024-02-09 3.5
2024-04-18 8.1 2024-02-08 3.4
2024-04-17 7.8 2024-02-07 3.4
2024-04-16 7.8 2024-02-06 3.5
2024-04-15 8.2 2024-02-05 3.6
2024-04-12 8.2 2024-02-02 3.5
2024-04-11 8.2 2024-02-01 3.5
2024-04-10 8.3 2024-01-31 3.5
2024-04-09 8.7 2024-01-30 3.6
2024-04-08 8.7 2024-01-29 3.6
2024-04-05 8.5 2024-01-26 3.6

Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.